Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
7
×
life sciences
national blog main
national top stories
biotech
boston blog main
boston top stories
gene therapy
hemophilia
new york blog main
new york top stories
san francisco blog main
san francisco top stories
clinical trials
fda
national
novartis
raleigh-durham blog main
san diego blog main
san diego top stories
spark therapeutics
zolgensma
biomarin pharmaceutical
bluebird bio
boulder/denver blog main
boulder/denver top stories
cancer
car-t
crispr
detroit blog main
detroit top stories
europe blog main
indiana blog main
indiana top stories
medicaid
pfizer
raleigh-durham top stories
roche
san francisco
sangamo therapeutics
What
therapy
7
×
gene
deal
therapeutics
bio
drug
fda
help
long
medicine
moves
patients
roundup
access
advanced
age
approval
aren’t
becker
betting
bigger
biggest
billion
billions
biopharma
building
capacity
car
cell
come
consolidation
crispr
crude
cutting
despite
developer
developers
disease
dollars
drugs
Language
unset
Current search:
therapy
×
deals
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed